{Reference Type}: Journal Article
{Title}: The advantages, disadvantages, threats, and opportunities of electronic patient-reported outcome systems in cancer: A systematic review.
{Author}: Salmani H;Nasiri S;Ahmadi M;
{Journal}: Digit Health
{Volume}: 10
{Issue}: 0
{Year}: 2024 Jan-Dec
{Factor}: 4.687
{DOI}: 10.1177/20552076241257146
{Abstract}: <B>UNASSIGNED: </B>Electronic patient-reported outcome (ePRO) systems hold promise for revolutionizing communication between cancer patients and healthcare providers across various care settings. This systematic review explores the multifaceted landscape of ePROs in cancer care, encompassing their advantages, disadvantages, potential risks, and opportunities for improvement.<BR><B>UNASSIGNED: </B>In our systematic review, we conducted a rigorous search in Scopus, Web of Science, and PubMed, employing comprehensive medical subject heading terms for ePRO and cancer, with no date limitations up to 2024. Studies were critically appraised and thematically analyzed based on inclusion and exclusion criteria, including considerations of advantages, disadvantages, opportunities, and threats.<BR><B>UNASSIGNED: </B>Analyzing 85 articles revealed 69 themes categorized into four key areas. Advantages (n = 14) were dominated by themes like "improved quality of life and care." Disadvantages (n = 26) included "limited access and technical issues." Security concerns and lack of technical skills were prominent threats (n = 10). Opportunities (n = 19) highlighted advancements in symptom management and potential solutions for technical challenges.<BR><B>UNASSIGNED: </B>This review emphasizes the crucial role of continuous exploration, integration, and innovation in ePRO systems for optimizing patient outcomes in cancer care. Beyond traditional clinical settings, ePROs hold promise for applications in survivorship, palliative care, and remote monitoring. By addressing existing limitations and capitalizing on opportunities, ePROs can empower patients, enhance communication, and ultimately improve care delivery across the entire cancer care spectrum.